Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Neurelis CEO and leadership

Zippia score 4.2
OverviewRevenue

Reviews

Competitors

CEO & Executives

Neurelis CEO and executives

Executive Summary. Based on our data team's research, Craig C. Chambliss is the Neurelis's CEO. Neurelis has 300 employees, of which 15 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Neurelis executive team is 20% female and 80% male.
  • 57% of the management team is White.
  • 18% of Neurelis management is Hispanic or Latino.
  • 9% of the management team is Black or African American.
Work at Neurelis?
Share your experience

Rate Neurelis' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Craig C. Chambliss

CEO / President

Craig C. Chambliss's LinkedIn

Specialties: Corporate development, commercial operations, business development, regulatory, product development, mergers & acquisitions, fundraising

David F. Hale

Board Member

Adrian Rabinowicz

SVP

Chuck Dewildt

Senior Vice President

Chuck Dewildt works at Cephalon Pharmaceuticals and an Head:Market Access & Reimbursement at Teva Pharmaceutical Indus Ltd and Chief Commercial Officer at Neurelis Inc. He has experience at Dupont Pharmaceuticals and has worked as VP:Market Access at Teva Pharmaceutical Indus Ltd and Senior VP:Commercial & Market Access at Neurelis Inc.

Brittany Bradrick

Chief Financial Officer

Enrique Carrazana

Board Member

Enrique Carrazana's LinkedIn

Collaborative, execution-oriented and pragmatic leader with 20+ years of Global Drug Development and Pharmaceutical Business, serving in both C-Suite and Board of Directors roles. I am driven by innovation & breakthrough thinking towards delivery of therapies that address unmet patients’ needs; as reflected by our Neurelis Team most recent accomplishment - the approval of VALTOCO (diazepam nasal spray) for rescue treatment of seizure clusters.

George Stuart

Chief Financial Officer

David V. Smith

Board Member

Edward F. Smith III

Senior Vice President

Jenny Alonso

General Counsel and Chief Compliance Officer

Do you work at Neurelis?

Does the leadership team provide a clear direction for Neurelis?

Neurelis jobs

Neurelis founders

Name & TitleBio
Craig C. Chambliss

CEO / President

Craig C. Chambliss's LinkedIn

Specialties: Corporate development, commercial operations, business development, regulatory, product development, mergers & acquisitions, fundraising

David F. Hale

Board Member

Neurelis board members

Name & TitleBio
Craig C. Chambliss

CEO / President

Craig C. Chambliss's LinkedIn

Specialties: Corporate development, commercial operations, business development, regulatory, product development, mergers & acquisitions, fundraising

David F. Hale

Board Member

Adrian Rabinowicz

SVP

Enrique Carrazana

Board Member

Enrique Carrazana's LinkedIn

Collaborative, execution-oriented and pragmatic leader with 20+ years of Global Drug Development and Pharmaceutical Business, serving in both C-Suite and Board of Directors roles. I am driven by innovation & breakthrough thinking towards delivery of therapies that address unmet patients’ needs; as reflected by our Neurelis Team most recent accomplishment - the approval of VALTOCO (diazepam nasal spray) for rescue treatment of seizure clusters.

David V. Smith

Board Member

Kevin Li

Board Member

Stuart Madden

Chief Scientific Officer

Cam Garner

Board Member

Neurelis executives FAQs

Related company executives

Working at related companies

Related company jobs

Most in demand jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of Neurelis, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Neurelis. The employee data is based on information from people who have self-reported their past or current employments at Neurelis. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Neurelis. The data presented on this page does not represent the view of Neurelis and its employees or that of Zippia.

Neurelis may also be known as or be related to Neurelis, Neurelis Inc and Neurelis, Inc.